Commission's MDD (Medical Devices Directive) review on track
This article was originally published in Clinica
The ongoing review of the Medical Devices Directive was among the issues that dominated the agenda of the European Commission's Medical Device Expert Working Group meeting on June 30-July 1. Indeed there was a full day of discussions devoted to this subject alone, giving all players in the sector, including regulators and industry, a chance to comment.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.